Close work with intellectual property counsel to track the evolution of the design and development of new technology

Application of business resources to bring downstream product development considerations upstream

Provision of funds to perform specific, determinative “killer” experiments to get to human studies (as required) and to patients as quickly as possible

Execution of projects in a managed process with measurable outcomes that will enable a “go/no-go” decision by commercial partners

Adaption to new information that may take the project down a path to a different application or technical approach or, even, to quit while ahead

How much funding is available?

Up to $700,000 of funding is available to support projects selected in the 2014 cycle, with an additional $300,000 worth of in-kind resources (marketing, regulatory, reimbursement, and legal). There is no funding limit per project. All projects and their budgets are evaluated on their own merits. Generally, the requested budget should be appropriate to the size of the commercial opportunity.

How many projects will be funded?

There is no set number of projects. Historically, 5 to 6 projects have been funded per year.